301. Letter from Harold Varmus to Anthony L. Schincariol, Duke University Medical Center

Format:

Text

302. Letter from Anthony Fauci, National Institutes of Health to Harold Varmus

Format:

Text

303. Letter from Brian Willoughby to Harold Varmus

Format:

Text

304. Letter from Jonathan W. M. Gold, Memorial Sloan-Kettering Cancer Center to Harold Varmus

Format:

Text

305. Letter from Donald I. Abrams, San Francisco General Hospital Medical Center to Harold Varmus

Format:

Text

306. Letter from Marcus A. Conant, University of California, San Francisco to Harold Varmus

Format:

Text

307. Harold Varmus, MD and J. Michael Bishop, MD

Format:

Text

308. Bishop and Varmus Win the Nobel Prize

Format:

Text

309. Naming the AIDS Virus

Format:

Text

310. Letter from Harold Varmus to Richard Lerner, Scripps Clinic and Research Foundation

Format:

Text

311. Tumor Viruses

Format:

Text

312. Small DNA Viruses

Format:

Text

313. Retroviruses

Format:

Text

314. A Proposal for a Workshop to Consider Structural and Procedural Changes in the NIH Office of Scientific Integrity

Format:

Text

315. Interview with Harold Varmus on teaching science

Format:

Text

316. Letter from Gunther S. Stent to Harold Varmus

Format:

Text

317. Letter from George W. Gekas, Bill Richardson, Sonny Callahan, and Ronald V. Dellums, United States House of Representatives to President Bill Clinton [on recommending Harold Varmus as NIH Director]

Format:

Text

318. Letter from Peter J. Fischinger, National Cancer Institute to Harold Varmus

Format:

Text

319. Letter from Peter K. Vogt, University of Southern California School of Medicine to Harold Varmus

Format:

Text

320. Recent Evidence for Oncogenesis by Insertion Mutagenesis and Gene Activation

Format:

Text

321. Letter from Harold Varmus to Peter Bentvelzen, Radiobiological Institute of the Organization for Health Research (The Netherlands)

Format:

Text

322. Letter from Harold Varmus, Warren Levinson, and J. Michael Bishop to Peter K. Vogt, University of Washington School of Medicine

Format:

Text

323. Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the results of the final poll on the nomenclature of the AIDS virus]

Format:

Text

324. Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on their final response on the nomenclature of the AIDS virus]

Format:

Text

325. Letter from Harold Varmus to Dani P. Bolognesi, Duke University Medical Center

Format:

Text

326. Letter from David Baltimore, Whitehead Institute to Harold Varmus

Format:

Text

327. Letter from Werner Henle, Children's Hospital of Philadelphia to Harold Varmus

Format:

Text

328. On the Nomenclature of Viruses Associated with AIDS

Format:

Text

329. Lab notes from the "nuclei and cytoplasmic 7x-3T3 clones" folder

Format:

Text

330. Letter from Harold Varmus to Senator Tom Harkin

Format:

Text

331. Stanford Medical School Graduation Speech

Format:

Text

332. EMail from Diane Wax to Harold Varmus

Format:

Text

333. Hearing Report: Summary of Panel 3 [on subject of alternative medicine research at NIH]

Format:

Text

334. Letter from Barbara McGarey to Harold Varmus

Format:

Text

335. Memorandum from Harold Varmus to the Secretary of Health and Human Services

Format:

Text

336. Discussion Points for NIH Technology Transfer Advisory Committee

Format:

Text

337. Reasons to Oppose Establishment of a National Center for Complementary and Alternative Medicine

Format:

Text

338. Minutes of the NIH NCCAM Trans-Agency CAM Coordinating Committee

Format:

Text

339. Letter from Herbert W. Boyer, Philip Coffino, and Harold Varmus to Daphne Kamely, National Institute of General Medical Sciences

Format:

Text

340. Letter from Harold Varmus to Michael G. P. Stoker, Imperial Cancer Research Fund Laboratories

Format:

Text

341. Letter from Michael G. P. Stoker, Imperial Cancer Research Fund Laboratories to Harold Varmus

Format:

Text

342. Letter from Mike Fried, Imperial Cancer Research Fund Laboratories to Harold Varmus

Format:

Text

343. Letter from Harold Varmus to Mike Fried, Imperial Cancer Research Fund Laboratories

Format:

Text

344. Testimony by Harold Varmus, MD, to the Senate Judiciary Committee Hearing on Human Cloning

Format:

Text

345. Testimony of Paul Berg, PhD, to the Senate Judiciary Committee Hearing [on Human Cloning]

Format:

Text

346. Letter from Harold Varmus to Ed Southern, Medical Research Council of Great Britain

Format:

Text

347. Letter from Harold Varmus to Girish N. Vyas

Format:

Text

348. Oncogenesis without Viral Oncogenes by Avian Leukosis and Mouse Mammary Tumor Viruses

Format:

Text

349. Letter from Harold Varmus to Hsing-Jien Kung, Michigan State University

Format:

Text

350. Letter from the Passano Foundation to Harold Varmus and J. Michael Bishop

Format:

Text

351. Letter from Harold Varmus to the Passano Foundation

Format:

Text

352. Letter from Hsing-Jien Kung, Michigan State University to Harold Varmus

Format:

Text

353. Letter from J. Michael Bishop to colleagues at the UCSF School of Medicine

Format:

Text

354. Letter from Harold Varmus and J. Michael Bishop to Robert J. Huebner, National Cancer Institute

Format:

Text

355. Letter from Harold Varmus to D. P. Georgiev, Academy of Sciences (U.S.S.R.)

Format:

Text

356. Letter from Harold Varmus to Alan C. Davis, American Cancer Society

Format:

Text

357. National Institutes of Health in the Tropics

Format:

Text

358. KRAS Mutations and Primary Resistance of Lung Adencarcinomas to Gefitnib or Erlotinib

Format:

Text

359. Three Decades of Wnts: A Personal Perspective on How a Scientific Field Developed

Format:

Text

360. Revitalization of the Warren G. Magnuson Clinical Center

Format:

Text